This meeting will bring the sector together to engage with recent advances in our capability to make biological medicines with five scientific sessions, an early career event, two dedicated poster sessions plus a chance to interact with our technology-provider exhibitors.

Confirmed speakers include: Kevin Vela (Cell and Gene Therapy Catapult), Molly Stevens (University of Oxford), David James (University of Sheffield), Sarah Dunn (AstraZeneca, UK), Alessandro Butte (DataHow, Switzerland), Christoph Herwig (Koerber Pharma, Germany), and Tom Ellis (Imperial College London).

More information and to register